08039432 is referenced by 5 patents and cites 135 patents.

The present invention provides methods of administering an insulinotropic peptide in an amount effective to treat a disorder or condition while reducing nausea side effect by administering to a subject in need thereof an insulinotropic peptide conjugated to albumin. The present invention also provides methods of selecting a subject for administration of a conjugated insulinotropic peptide. Exemplary disorders or conditions treatable with an insulinotropic peptide include obesity and type II diabetes.

Title
Method of treatment of diabetes and/or obesity with reduced nausea side effect
Application Number
11/595576
Publication Number
8039432 (B2)
Application Date
November 9, 2006
Publication Date
October 18, 2011
Inventor
Karen Thibaudeau
Rosemere
CA
Jean Paul Castaigne
Mont-Royal
CA
Dominique P Bridon
San Francisco
CA, US
Agent
Morrison & Foerster
Assignee
Conjuchem
CA, US
IPC
A61K 38/38
A61K 38/28
A61K 38/26
View Original Source